iMeds.se

Oxycodone Orion

Document: Oxycodone Orion 10 mg per ml solution for injection or infusion ENG PL change

Package leaflet: Information for the patient


Oxycodone Orion 10 mg/ml solution for injection/infusion


Oxycodone hydrochloride


Read all of this leaflet carefully before you are given this medicine because it contains important information for you.


What is in this leaflet

1. What Oxycodone Orion is and what it is used for

2. What you need to know before you are given Oxycodone Orion

3. How to use Oxycodone Orion

4. Possible side effects

How to store Oxycodone Orion

6. Contents of the pack and other information


What Oxycodone Orion is and what it is used for


This solution for injection/infusion contains the active ingredient oxycodone, which belongs to a group of medicines called opioids.


This medicinal product is prescribed for you by your doctor to relieve severe pain which can be adequately managed only with opioid analgesics.


What you need to know before you are given Oxycodone Orion


Do not use Oxycodone Orion


- if you are allergic to oxycodone or any of the other ingredients of this medicine (listed in section 6)

- if you have severe breathing problems


Warnings and precautions


Talk to your doctor, before you are given Oxycodone Orion

- if you have severely impaired lung function


Tell your doctor during treatment

- when your bowels does not work properly. This may indicate intestinal obstruction and then the treatment should be stopped immediately.

if your pain is not relieved even if the oxycodone dose is increased.


Long‑term use

Use of Oxycodone Orion over long periods can cause physical dependence. Therefore, the dose should be reduced gradually when treatment is stopped (see section 3, “If your treatment with Oxycodone Orion is stopped”).


Children

There is not enough information to recommend the use of Oxycodone Orion to children.


Other medicines and Oxycodone Orion


Tell your doctor if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription. If you use Oxycodone Orion with some other medicines, the effect of this injection/infusion or the other medicines may be changed.


Tell your doctor or pharmacist if you are taking


Oxycodone Orion with food, drink and alcohol


Oxycodone Orion solution for injection/infusion can be used with food and drink. However, avoid grapefruit juice as it can affect oxycodone plasma levels.


Alcohol

Do not drink alcohol during treatment. Alcohol can enhance some dangerous side effects of oxycodone, such as severe breathing problems, when used during treatment.


Pregnancy and breast-feeding


If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.


The use of Oxycodone Orion should be avoided to the extent possible during pregnancy and breast-feeding.


Pregnancy

There are limited data from the use of oxycodone in pregnant women. Oxycodone crosses the placenta into the blood circulation of the baby. Use of oxycodone during pregnancy may cause withdrawal symptoms in the newborn. Infants born to mothers who have recieved oxycodone during the last 3-4 weeks before labour can cause severe breathing difficulties in the newborn. Oxycodone Orion should only be used during pregnancy if the benefit outweighs the possible risks to the baby.


Breast-feeding

Oxycodone may pass into breast milk and may cause breathing difficulties in the newborn. Oxycodone Orion should therefore not be used during breast-feeding.


Driving and using machines


This medicinal product may impair your reaction and cause side effects such as dizziness and sleepiness which could effect your ability to drive or use machines. These are usually most noticeable when you first start using Oxycodone Orion, or when changing to a higher dose. Do not drive or use any tools or machines if you are affected.


Oxycodone Orion contains sodium


This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium-free’.


How to use Oxycodone Orion


Your doctor prescribes the dose individually to you according to your age, the severity of your pain, the general condition, possible concomitant diseases, and your previous and concomitant medication. A healthcare professional will prepare and give this medicinal product to you either as an injection (under the skin, into a vein or into a muscle) or as a drip (under the skin or into a vein).


You will be given Oxycodone Orion for as short a period of time as possible.


Instructions for use for medical or healthcare professionals are provided at the end of this leaflet.


If you are given more Oxycodone Orion than you should


Oxycodone Orion is given to you by healthcare professionals. An overdose is therefore unlikely. If you have received more medicine than you should have, contact your doctor or hospital immediately.


The symptoms for overdose are small pupils, severe breathing problems, sleepiness, skeletal muscle flaccidity, slow heart rate and too low blood pressure. In severe cases even coma and death may occur. When seeking medical attention take this leaflet and any remaining solution for injection or infusion with you and show to the doctor.


If your treatment with Oxycodone Orion is stopped


You should not suddenly stop using this medicine unless your doctor tells you to. If you want to stop using your injection, discuss this with your doctor first. The dose is usually reduced gradually, so that you do not experience unpleasant effects. Abrupt withdrawal of treatment can cause withdrawal symptoms such as restlessness, runny eyes and nose, sweats and broken sleep within 24 hours.


If you have any further questions on the use of this product, ask your doctor or nurse.


4. Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.


This medicine can in some uncommon cases cause severe side effects. Stop taking Oxycodone Orion and contact your doctor immediately if following symptoms occur:


Oxycodone can also cause following side effects:


Very common (may affect more than 1 in 10 people):

dizziness, sleepiness, headache


Common (may affect up to 1 in 10 people):


Uncommon (may affect up to 1 in 100 people):


Rare (may affect up to 1 in 1,000 people):

allergic reaction, severe hypersensitivity reactions.


Not known (frequency cannot be estimated from the available data):


Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.


5. How to store Oxycodone Orion


Keep this medicine out of the sight and reach of children.


Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month.


This medicine does not require any special temperature storage conditions. Store in the original package in order to protect from light. Once the ampoule is opened the solution for injection/infusion should be used immediately. Any unused portion should be discarded.


Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.


6. Contents of the pack and other information


What Oxycodone Orion contains



What Oxycodone Orion looks like and contents of the pack


Oxycodone Orion solution for injection/infusion is a clear, colourless solution.

It is supplied in glass ampoules packed in cardboard boxes including 5 x 1 ml, 5 x 2 ml or 5 x 10 ml.

Not all pack sizes may be marketed.


Marketing Authorisation Holder and Manufacturer


Marketing Authorisation Holder

Orion Corporation

Orionintie 1

FI‑02200 Espoo

Finland


Manufacturer

Orion Corporation Orion Pharma

Orionintie 1

FI‑02200 Espoo

Finland


This medicinal product is authorised in the Member States of the EEA under the following names:


Denmark:Oxycodone Orion 10 mg/ml injektions- og infusionsvæske, opløsning

Finland: Oxycodone Orion 10 mg/ml injektio- / infuusioneste, liuos

Sweden: Oxycodone Orion 10 mg/ml injektions-/infusionsvätska, lösning


This leaflet was last revised in 15 July 2016


<[To be completed nationally]>


Detailed information on this medicine is available on the website of {MS/Agency}


-----------------------------------------------------------------------------------------------------------------------------

The following information is intended for healthcare professionals only. See SmPC for more information.


These instructions provide technical information about Oxycodone Orion 10 mg/ml solution for injection/infusion.


Instructions for use/handling


Use solution for injection/infusion immediately after opening. Any unused portion should be discarded.


If needed, dilute with 9 mg/ml (0.9%) saline or 50 mg/ml (5%) glucose or water for injections.


If Oxycodone Orion injection/infusion is used concurrently with cyclizine, mixed solution is diluted with water for injections. 9 mg/ml (0.9%) sodium chloride solution must not be used. If the concentration of cyclizine in the mixed combination is under 3 mg/ml, mixture is physically and chemically stable for 24 hours at room temperature. If the concentration of cyclizine in the mixture is over 3 mg/ml, solution is unstable and may be precipitated.


Prochlorperazine is chemically incompatible with Oxycodone Orion injection/infusion.


Oxycodone Orion injection/infusion, undiluted or diluted to 9 mg/ml (0.9%) sodium chloride solution, 50 mg/ml (5%) glucose solution or water for injections is physically and chemically stable when in contact with polypropylene or polycarbonate syringes, polyethylene or PVC tubing and PVC, EVA, polyolefin / polyamide, low density polyethylene and polypropylene infusion bags, over 24 hours at room temperature.


The injection/infusion, whether undiluted or diluted, does not need to be protected from light, if it is used with the solution for infusion and equipment combinations used in these studies.


Inappropriate handling of the undiluted solution after opening of the original ampoule, or of the diluted solutions may compromise the sterility of the product.


Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

1